Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.

Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.

Biokinetics of yttrium-90–labeled huBrE-3 monoclonal antibody.